MedPath

Comparison of the effect of fenugreek (Moota) with metformin tablets in improving clinical symptoms and metabolic status of patients with polycystic ovary syndrome (PCOS)

Phase 3
Conditions
Polycystic ovary syndrome.
Polycystic ovarian syndrome
E28.2
Registration Number
IRCT20220130053874N1
Lead Sponsor
Iran University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
Female
Target Recruitment
110
Inclusion Criteria

1. Female infertility (ovarian factor)
2. Having two of the three criteria of polycystic ovary syndrome: oligomenorrhea or amenorrhea, clinical or biochemical symptoms of hyperandrogenism, polycystic ovaries in ultrasonographic view.
4. Fasting blood sugar (FBS) less than 200 mg / dL 5. Normal liver and kidney function (serum creatinine less than 1.4 mg / dL)

Exclusion Criteria

History of medical conditions such as diffuse blood infection, renal failure, congestive heart failure, disorders of chemical characteristics of the kidney, gastrointestinal problems.
Type 1 diabetes
Adrenal disorders
Hypothyroidism
Use of other blood sugar medications

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Improve clinical symptoms. Timepoint: At the beginning of the intervention. Method of measurement: By checklist.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath